1292 Inorg. Chem. 2010, 49, 1292–1294
DOI: 10.1021/ic9022163
Titanocene Difluorides with Improved Cytotoxic Activity
‡
Silvia Eger,† Timo A. Immel,† James Claffey,‡ Helge Muller-Bunz, Matthias Tacke,‡ Ulrich Groth,† and
€
Thomas Huhn*,†
‡Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4,
†
€
Ireland and Fachbereich Chemie and Konstanz Research School Chemical Biology, Universitat Konstanz,
€
Universitatsstrasse 10, Fach 720, 78457 Konstanz, Germany
Received November 10, 2009
Titanocene difluorides can be obtained by halide metathesis of
the respective titanocene dichlorides with trimethyltin fluoride
(Me3SnF), giving access to a new class of cytotoxic active sub-
stances. Furthermore, an improved method for the synthesis of
diaryl-substituted titanocene dichlorides is presented.
for oxalititanocene Y (titanocene Y with both chloride ligands
substituted by the bidentate oxalate).6 We were interested in
the synthesis and cytotoxicity of fluorotitanocene derivatives
because of their anticipated higherstability againstsolvolysis;
the Ti-F bond is known to be more stable by 75 kcal/mol
than the Ti-Cl bond.7
Within this paper, we introduce several benzyl- and diaryl-
substituted titanocene difluorides that can be obtained by
fluorinating the respective TDCs with trimethyltin fluoride.
Preliminary cytotoxicity studies show that the fluorine ana-
logue of titanocene Y is 4-7 times more cytotoxic than
titanocene Y itself. Furthermore, we present an improved
method for the synthesis of diaryl-substituted TDCs.
For comparative cytotoxicity studies between TDCs and
titanocene difluorides, two different classes of titanocene
derivatives have been synthesized.
Three different benzyl-substituted TDCs [m- (3a), p- (3b),
and 3,5-dimethoxybenzyl (3c)] were synthesized according to
Sweeney et al.4 Selected fulvenes 1 are hydridolithiated by
LiB(Et)3H (SuperHydride) to give the corresponding lithium
cyclopentadienides 2, which were, in turn, transmetalated with
TiCl4 to yield bis(benzyl)titanocene dichlorides 3 (Scheme 1).
The second class of titanocene derivatives, diaryl-substi-
tuted titanocenes 7, was primarily synthesized according to a
one-pot procedure, consisting of halogen-lithium exchange,
fulvene addition, and transmetalation by TiCl4 published by
Pampillion et al.8
Neither thehalogenmetalexchangenor the carbolithiation
of the respective fulvene 1 might proceed to completeness;
i.e., the amount of lithium cyclopentadienide 6 is difficult to
estimate. However, an excess of titanium tetrachloride leads
to cyclopentadienyltitanium(IV) trichlorides, while an excess
of ligand facilitates the reduction of titanium(IV) to titanium-
(III) species. These byproducts hamper the isolation of the
target molecule because the respective TDCs 7 are difficult to
purify. Because the solubility of lithium cyclopentadienides 6
in diethyl ether is rather limited, the halogen-lithium ex-
change was set up with 2 equiv of tert-BuLi in Et2O instead of
Titanocene dichloride (TDC; Cp2TiCl2) attracted great
interest because it was the first non-platinum complex to
show promising results as an antitumor agent. It reached
clinical trials, but the efficacy of Cp2TiCl2 in phase II clinical
trials in patients with metastatic renal cell carcinoma1 or
metastatic breast cancer2 was too low to be pursued.
More recently, a large number of differently substituted
titanocene derivatives have been synthesized and tested for
their potential cytotoxicity.3 By substitution of the cyclopen-
tadienyl (cp) rings, the cytotoxicity in LLC-PK cells could be
increased by a factor of 1000. The p-methoxybenzyl-substi-
tuted titanocene Y (1b) shows an IC50 value of 21 μM,4 and
the dimethylamino-functionalized and heteroaryl-substi-
tuted titanocene C shows an IC50 value of 5.5 μM,5 compared
to 2 mM for Cp2TiCl2.
Furthermore, the cytotoxic activity can be influenced by
substitution of the two chloride ligands. The nature of these
two “not-cp-ligands” affects the hydrolytic stability and
thereby the bioavailability of the active substance. Ligands
that show a higher hydrolytic stability than chloride but can
still be hydrolyzed under physiological conditions seem to be
ideal. Recently, Claffey et al. reported an IC50 value of 1.6 μM
*To whom correspondence should be addressed. E-mail: thomas.huhn@
uni-konstanz.de. Fax: þ49-7531-884424.
(1) Lummen, G.; Sperling, H.; Luboldt, H.; Otto, T.; Rubben, H. Cancer
Chemother. Pharmacol. 1998, 42, 415–417.
€
(2) Kroger, N.; Kleeberg, U. R.; Mross, K. B.; Edler, L.; Sass, G.;
Hossfeld, D. K. Onkologie 2000, 23, 60–62.
(3) Strohfeld, K.; Tacke, M. Chem. Soc. Rev. 2008, 37, 1174–1187.
€
(4) Sweeney, N. J.; Mendoza, O.; Muller-Bunz, H.; Pampillon, C.;
Rehmann, F. K.; Strohfeldt, K.; Tacke, M. J. Organomet. Chem. 2005,
690, 4537–4544.
(5) Pampillon, C.; Sweeney, N.; Strohfeld, K.; Tacke, M. J. Organomet.
Chem. 2007, 692, 2153–2159.
(7) Hudlicky, M. Chemistry of Organic Fluorine Compounds;A Labora-
tory Manual; Ellis Horwood Ltd. and John Wiley & Sons: New York, 1976.
(8) Pampillon, C.; Mendoza, O.; Sweeney, N. J.; Strohfeldt, K.; Tacke, M.
Polyhedron 2006, 25, 2101–2108.
€
ꢀ
(6) Claffey, J.; Hogan, M.; Muller-Bunz, H.; Pampillon, C.; Tacke, M.
ChemMedChem 2008, 3, 729–731.
r
pubs.acs.org/IC
Published on Web 01/07/2010
2010 American Chemical Society